Le Lézard
Classified in: Health
Subject: LAW

Robert G. Miller will always fight for the truth


WESTMOUNT, QC, July 3, 2024 /CNW/ - Recognized throughout his life for his honesty, integrity and philanthropy, Robert G. Miller remains true to himself and asserts his innocence to the charges against him. He once again refutes these false allegations made with the sole objective of unworthy financial gain at his expense.

His reputation has always been impeccable and recognized, both personally and in business. Throughout his life, all his relationships have been honest, consensual and pleasant.

His health challenges are well known. M. Miller, who turns 81 today, has been fighting a battle against Parkinson's disease for the last 28 years. He is bedridden and on oxygen. Despite these challenges, which prevent him from defending himself, Robert G. Miller intends to take all available means to restore his reputation.

SOURCE Robert G. Miller


These press releases may also interest you

at 12:07
The Women in Insurance Cancer Crusade (WICC) took another step closer to its goal of raising $25 million by 2025 at their annual Relay for Life fundraising event, held on June 6th . Nearly 300 people came together for an evening of camaraderie for...

at 12:00
"I wanted to create a simple and attractive way to secure your glasses to your shirt, jacket or other article of clothing," said an inventor, from Port St. Lucie, Fla., "so I invented the EYEGLASS PIN HOLDER. My design enables you to keep your...

at 11:56
Northwest Biotherapeutics ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, reported positive results of voting at the Annual Shareholders Meeting on June 29, 2024. ...

at 11:32
The American Parkinson Disease Association (APDA) is celebrating the President's signing of the National Plan to End Parkinson's Act yesterday, marking the enactment of the first-ever federal legislation dedicated to curing and preventing Parkinson's...

at 11:30
NeuroCytonix, Inc., today announced that on May 27, 2024, its subsidiary NeuroCytonix Mexico received a regulatory approval letter from the ethical, scientific, and safety committees of Hospital La Mision in Monterrey, Mexico, to launch a clinical...

at 11:00
States with high rates of COVID-19 vaccination saw more pediatric asthma patients get a break from their symptoms, according to new research published today in JAMA Network Open by leaders from Nemours Children's Health and Endeavor Health....



News published on and distributed by: